These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9661815)

  • 1. Fine tuning of an anti-testosterone antibody binding site by stepwise optimisation of the CDRs.
    Hemminki A; Niemi S; Hautoniemi L; Söderlund H; Takkinen K
    Immunotechnology; 1998 Jun; 4(1):59-69. PubMed ID: 9661815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity improvement of a recombinant anti-testosterone Fab fragment by CDRIII mutagenesis and phage display selection.
    Hemminki A; Niemi S; Hoffrén AM; Hakalahti L; Söderlund H; Takkinen K
    Protein Eng; 1998 Apr; 11(4):311-9. PubMed ID: 9680193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering the steroid-specificity of an anti-17beta-estradiol Fab by random mutagenesis and competitive phage panning.
    Saviranta P; Pajunen M; Jauria P; Karp M; Pettersson K; Mäntsälä P; Lövgren T
    Protein Eng; 1998 Feb; 11(2):143-52. PubMed ID: 9605549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of an in vitro affinity- and specificity-matured anti-testosterone Fab in complex with testosterone. Improved affinity results from small structural changes within the variable domains.
    Valjakka J; Hemminki A; Niemi S; Söderlund H; Takkinen K; Rouvinen J
    J Biol Chem; 2002 Nov; 277(46):44021-7. PubMed ID: 12196551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the binding energies of testosterone, 5alpha-dihydrotestosterone, androstenedione and dehydroepiandrosterone sulfate with an antitestosterone antibody.
    Nordman N; Valjakka J; Peräkylä M
    Proteins; 2003 Jan; 50(1):135-43. PubMed ID: 12471606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of antibody single-chain variable fragments with improved carbohydrate binding by phage display.
    Deng SJ; MacKenzie CR; Sadowska J; Michniewicz J; Young NM; Bundle DR; Narang SA
    J Biol Chem; 1994 Apr; 269(13):9533-8. PubMed ID: 8144539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of anti-Burkholderia mouse monoclonal antibody from various phage-displayed single-chain antibody libraries.
    Kim HS; Lo SC; Wear DJ; Stojadinovic A; Weina PJ; Izadjoo MJ
    J Immunol Methods; 2011 Sep; 372(1-2):146-61. PubMed ID: 21787781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range.
    Yang WP; Green K; Pinz-Sweeney S; Briones AT; Burton DR; Barbas CF
    J Mol Biol; 1995 Dec; 254(3):392-403. PubMed ID: 7490758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for a specificity switch and for maintenance of affinity using mutational analysis of a phage-displayed anti-arsonate antibody of Fab heavy chain first complementarity-determining region.
    Wong YW; Gill DS; Parhami-Seren B; Short MK; Sompuram SR; Margolies MN
    J Immunol; 1998 Jun; 160(12):5990-7. PubMed ID: 9637513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antibody maturation. Improvement of a high affinity, neutralizing antibody against IL-1 beta.
    Jackson JR; Sathe G; Rosenberg M; Sweet R
    J Immunol; 1995 Apr; 154(7):3310-9. PubMed ID: 7897213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and expression of human V-genes derived from phage display libraries as fully assembled human anti-TNF alpha monoclonal antibodies.
    Mahler SM; Marquis CP; Brown G; Roberts A; Hoogenboom HR
    Immunotechnology; 1997 Mar; 3(1):31-43. PubMed ID: 9154466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.
    Schier R; McCall A; Adams GP; Marshall KW; Merritt H; Yim M; Crawford RS; Weiner LM; Marks C; Marks JD
    J Mol Biol; 1996 Nov; 263(4):551-67. PubMed ID: 8918938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.
    Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G
    J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Random mutagenesis of two complementarity determining region amino acids yields an unexpectedly high frequency of antibodies with increased affinity for both cognate antigen and autoantigen.
    Casson LP; Manser T
    J Exp Med; 1995 Sep; 182(3):743-50. PubMed ID: 7650481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of affinity matured scFv antibodies against mouse neural cell adhesion molecule L1 by phage display.
    Dong L; Chen S; Bartsch U; Schachner M
    Biochem Biophys Res Commun; 2003 Jan; 301(1):60-70. PubMed ID: 12535641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxin.
    Ho M; Kreitman RJ; Onda M; Pastan I
    J Biol Chem; 2005 Jan; 280(1):607-17. PubMed ID: 15491997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of monovalent fragments derived from a human IgM autoantibody in E. coli. The input of the somatically mutated CDR1/CDR2 and of the CDR3 into antigen binding specificity.
    Jahn S; Roggenbuck D; Niemann B; Ward ES
    Immunobiology; 1995 Aug; 193(5):400-19. PubMed ID: 8522357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
    Wang X; Campoli M; Ko E; Luo W; Ferrone S
    J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.